ストックスクリーナーアプリを入手
8.45
2.31%
-0.20
アフターアワーズ：
8.50
0.05
+0.59%
Sophia Genetics Sa (SOPH) 最新ニュース
SOPHiA GENETICS Chief Scientific Officer Xu Zhenyu Sells 20,000 Shares Over Three Days - Kalkine Media
SOPHiA GENETICS (NASDAQ: SOPH) officer may sell founder shares - Stock Titan
SOPHiA GENETICS (NASDAQ: SOPH) officer lines up 10,000-share sale - Stock Titan
SOPHiA GENETICS (NASDAQ: SOPH) officer plans additional 8,000-share sale - Stock Titan
SOPHiA GENETICS (NASDAQ:SOPH) Hits New 12-Month HighShould You Buy? - MarketBeat
EBIT per share of SOPHiA GENETICS SA – DUS:90B - TradingView
SOPHiA GENETICS SA (NASDAQ:SOPH) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
SOPHiA Genetics Earnings Call Highlights Growth Push - TipRanks
SOPHiA GENETICS (SOPH) Q2 2026 Earnings Call Transcript - AOL.com
Sophia Genetics SA (SOPH) Chief Scientific Officer Zhenyu Xu Sel - GuruFocus
SOPHiA GENETICS (SOPH) Slips 1.57% as Shares Consolidate Between Key Support and ResistanceStock Surge Alerts - vinanet.vn
SOPHiA GENETICS (NASDAQ:SOPH) Insider Philippe Menu Sells 5,000 Shares - MarketBeat
Insider Selling: SOPHiA GENETICS (NASDAQ:SOPH) Insider Sells 4,000 Shares of Stock - MarketBeat
SOPHiA GENETICS (SOPH) Slips 0.53% to $7.57 as Genomics AI Stock Consolidates Between Key LevelsSeasonality Effect - Vinanet
SOPHiA GENETICS (SOPH) Consolidates at $7.57: Genomics Stock Poised Between Support and ResistanceCorrective Wave - vinanet.vn
Sophia Genetics (SOPH) Executive Chairman Jurgi Camblong Sells 2 - GuruFocus
SOPHiA GENETICS (NASDAQ:SOPH) Reaches New 52-Week HighTime to Buy? - MarketBeat
Jurgi Camblong Sells 8,500 Shares of SOPHiA GENETICS (NASDAQ:SOPH) Stock - MarketBeat
Abhimanyu Verma Sells 5,000 Shares of SOPHiA GENETICS (NASDAQ:SOPH) Stock - MarketBeat
SOPHiA GENETICS (NASDAQ:SOPH) Chairman Sells 20,000 Shares - MarketBeat
Sei Investments Co. Buys Shares of 357,888 SOPHiA GENETICS SA $SOPH - MarketBeat
SOPHiA GENETICS (NASDAQ:SOPH) Insider Sells $123,930.00 in Stock - MarketBeat
SOPH (NASDAQ: SOPH) insider schedules 22,000-share sale under 10b5-1 plan - Stock Titan
SOPHiA GENETICS (SOPH) insider plans Rule 144 sale after 10b5-1 trades - Stock Titan
Sophia Genetics CSO Zhenyu Xu disposes of USD 170,872 in common shares - Bitget
SOPHiA GENETICS Q3 EPS Estimate Lowered by HC Wainwright - MarketBeat
Three Swiss biotechs widen their reach into pharma, paediatrics and lung disease - Startupticker.ch
HC Wainwright Predicts Reduced Earnings for SOPHiA GENETICS - MarketBeat
SOPHiA GENETICS (NASDAQ:SOPH) Insider Zhenyu Xu Sells 10,000 Shares - MarketBeat
SOPHiA GENETICS (NASDAQ:SOPH) Chairman Sells $138,400.00 in Stock - MarketBeat
BTIG raises Sophia Genetics stock price target on CDx deals By Investing.com - Investing.com South Africa
SOPHiA GENETICS (NASDAQ:SOPH) Hits New 52-Week High After Analyst Upgrade - MarketBeat
SOPH Stock Price and Chart — NASDAQ:SOPH - tradingview.com
BTIG Research Issues Positive Forecast for SOPHiA GENETICS (NASDAQ:SOPH) Stock Price - MarketBeat
SOPHiA GENETICS (NASDAQ:SOPH) Stock Price Expected to Rise, HC Wainwright Analyst Says - MarketBeat
SOPHiA GENETICS Updates Investors With Q2 2026 Form 6-K Filing - The Globe and Mail
BTIG raises Sophia Genetics stock price target on CDx deals - Investing.com
SOPHiA GENETICS partners with AstraZeneca for oncology diagnostics - Yahoo Finance
SOPHiA GENETICS (NASDAQ:SOPH) Shares Up 10.5%Here's Why - MarketBeat
Jurgi Camblong (SOPH) plans 20,000-share sale and details 10b5-1 trades - Stock Titan
SOPHiA GENETICS (SOPH) insider Zhenyu Xu plans 10,000-share stock sale - Stock Titan
Sophia Genetics SA (SOPH) (Q2 2026) Earnings Call Highlights: Record Revenue Growth and ... - Yahoo! Finance Canada
SOPHiA GENETICS Q2 Earnings Call Highlights - MarketBeat
Sophia Genetics SA and AstraZeneca Enter Collaboration to Develop Companion Diagnostics for Precision Oncology Therapies - marketscreener.com
SOPH: Q2 revenue up 27% year-over-year, guidance raised, and major biopharma wins secured - TradingView
Earnings call transcript: SOPHiA GENETICS tops revenue estimates in Q2 2026 - Investing.com
SOPH Looks 11.8% Overvalued on GF Value™ - GuruFocus
SOPHiA GENETICS (NASDAQ:SOPH) Issues Quarterly Earnings Results - MarketBeat
Sophia Genetics SA reports results for the quarter ended June 30Earnings Summary - TradingView
SOPH: Q2 2026 revenue rose 27% YoY, with strong U.S. and Liquid Biopsy growth and improved EBITDA loss - TradingView
[6-K] SOPHiA GENETICS SA Current Report (Foreign Issuer) - Stock Titan
BRIEF-SOPHiA GENETICS SA Q2 Revenue USD 23.3 Million - TradingView
SOPHiA GENETICS Reports Second Quarter 2026 Results - PR Newswire
H.C. Wainwright reiterates Sophia Genetics stock rating ahead of results - Investing.com
H.C. Wainwright reiterates Sophia Genetics stock rating ahead of results By Investing.com - Investing.com South Africa
SOPHiA GENETICS (SOPH) Slips 1.56% — Testing Key Support ZoneCovered Call Trade - vinanet.vn
Sophia Genetics SA expected to post a loss of 21 cents a shareEarnings Preview - TradingView
Jurgi Camblong Sells 20,000 Shares of SOPHiA GENETICS (NASDAQ:SOPH) Stock - MarketBeat
SOPHiA GENETICS (SOPH) Expected to Post Earnings on Tuesday - MarketBeat
SOPHiA Genetics CMO Philippe Menu Sells 5,000 Shares via Rule 10b5-1 Trading Plan on July 27, 2026 - Kalkine Media
Sophia Genetics SA (SOPH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Sophia Genetics SA (SOPH) Cash Flow - TradingKey
Sophia Genetics SA (SOPH) Institutional Confidence - TradingKey
SOPHiA GENETICS SA (NASDAQ:SOPH) Given Average Rating of "Hold" by Brokerages - MarketBeat
0.47%
0.90%
大文字化:
|
ボリューム (24 時間):